cancerous diseases
http://www.yso.fi/onto/yso/p678
Related publications
1 of 7
- Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial : Planned 10-Year Follow-up (2022) Mathers, John C.; et al.; A1; OA
- Exercise Medicine for Cancer Cachexia : Targeted Exercise to Counteract Mechanisms and Treatment Side Effects (2022) Mavropalias, Georgios; et al.; A2; OA
- Kakeksian mekanismit ja hoito (2022) Järvinen, Tommi; et al.; A2; OA
- Muscle metabolism and intercellular crosstalk : effects of in vitro cxercise and changes in muscle size (2022) Lautaoja, Juulia.; G5; OA; 978-951-39-9084-8
- Prognostic significance of spatial and density analysis of T lymphocytes in colorectal cancer (2022) Elomaa, Hanna; et al.; A1; OA
- Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study (2022) Uutela, Aki; et al.; A1; OA
- The different immune profiles of normal colonic mucosa in cancer-free Lynch syndrome carriers and Lynch syndrome colorectal cancer patients (2022) Bohaumilitzky, Lena; et al.; A1
- Descriptive study on subjective experience of genetic testing with respect to relationship, family planning and psychosocial wellbeing among women with lynch syndrome (2021) Kalamo, Mari; et al.; A1; OA
- IGF2BP3 Associates with Proliferative Phenotype and Prognostic Features in B-Cell Acute Lymphoblastic Leukemia (2021) Mäkinen, Artturi; et al.; A1; OA
- Immune cell score, PD-L1 expression and prognosis in esophageal cancer (2021) Junttila, Anna; et al.; A1
